Drug intelligence / Profile preview

recombinant human intrinsic factor

Development stage
Phase 2
Lead developer
Aarhus University
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Recombinant human intrinsic factor is a glycoprotein produced using recombinant DNA technology in various expression systems (such as HEK293 cells[1], Sf9 insect cells[3], plants[7][8], and microalgae[10]). It mimics the naturally occurring gastric intrinsic factor secreted by parietal cells of the stomach. Its primary function is to bind vitamin B12 (cobalamin) in the gastrointestinal tract and facilitate its absorption in the terminal ileum via specific receptors. Recombinant forms are used for diagnostic purposes (e.g., as a reagent in immunoassays for anti-intrinsic factor antibodies), research applications related to vitamin B12 metabolism and absorption testing[4][6][7][8], and potentially therapeutic use to restore or enhance vitamin B12 uptake in patients with deficiency due to lack of endogenous intrinsic factor. The mechanism of action involves high-affinity binding to dietary vitamin B12 and subsequent receptor-mediated endocytosis into enterocytes.

Brand names
Xeragenx human IF
Other names
gastric intrinsic factorintrinsic factorINFIFGIFIFMHTCN3TCN-3TCN 3cobalamin/vitamin B-12 binding transport protein
02

Targets

CUBN (Cubilin (intrinsic factor-vitamin B12 receptor))

Beyond the preview

Go deeper on recombinant human intrinsic factor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant human intrinsic factor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call